63 results on '"Benassi CA"'
Search Results
2. Drug protein interaction: displacement of albumin bound 8-methoxypsoralen by drugs
3. Tryptophan pyrrolase, kynureninase and kynurenine transaminase activities of human renal tumours
4. Silicon membrane interface for the direct analysis of Kathon CG in aqueous solutions and cosmetic emulsions.
5. Rapid pentachlorophenol evaluation in solid matrixes by second derivative UV spectroscopy for application to wood and leather samples.
6. Dowicil 200 Stability test: chemical and microbiological studies.
7. Properties and potential applications of arginase immobilized by radiation-induced polymerization of acrylic monomers.
8. The characterization of isothiazolinone preservatives in cosmetics.
9. The study of the furocoumarin-serum albumin complex by difference spectrophotometry and gel exclusion.
10. Histamine determination in tears as an index of safety in use of cosmetic products.
11. Determination of bergapten in suntan cosmetics.
12. Chemical stability and microbiological reply of preservative systems in cosmetics: a direct correlation.
13. Qualitative and quantitative determination of Prevan in cosmetic emulsions by direct analysis via fast atom bombardment/collisional spectroscopy.
14. Psychoactive butyrophenones: binding to human and bovine serum albumin.
15. High-performance liquid chromatographic determination of free formaldehyde in cosmetics.
16. New acrylic polymers for surface modification of enzymes of therapeutic interest and for enzyme immobilization.
17. [Quantitative evaluation of conjunctival irritation by simultaneous determination of histamine, serotonin and leukotriene C4 in tears].
18. Determination of coumarin and 6-methylcoumarin in cosmetics by high-performance liquid chromatography.
19. Purification, modification, physico-chemical and pharmacokinetic characterization of arginase, an enzyme of potential use in therapy.
20. [Use of oximinoiminopyrrazoline esters in the synthesis of solids phase peptides: synthesis of bradykinin].
21. Surface modification of proteins. Activation of monomethoxy-polyethylene glycols by phenylchloroformates and modification of ribonuclease and superoxide dismutase.
22. A rapid HPLC technique for determining levels of histamine in tears from normal and inflamed human eyes.
23. [Esters and amides of salicyloylamino acids].
24. Studies on trypsin inhibitors. Part IV, Synthesis of the protected undecapeptide (sequence 25-35) of porcine pancreatic secretory trypsin inhibitor II (Kazal).
25. Studies on trypsin inhibitors. Part I. Synthesis of protected peptides related to sequence 1-10 of porcine pancreatic secretory trypsin inhibitor II (Kazal).
26. Enzymatically active subunits of Bacillus stearothermophilus enolase bound to Sepharose.
27. Histamine in tears: developments in collection and HPLC-fluorimetric detection.
28. Histamine assay in tears by fluorescamine derivatization and high-performance liquid chromatography.
29. Crystal and molecular structure of a 4-oximino-5-imino-pyrazoline active ester.
30. On the reaction of acetamidomethanol with native and reduced bovine pancreatic trypsin inhibtor (Kunitz inhibitor).
31. Drug-protein interaction: the binding of cephalosporins to albumins.
32. Arginine modification in Kunitz bovine trypsin inhibitor through 1, 2-cyclohexanedione.
33. [Chromatographic research on biological derivatives of tryptophan].
34. Sulfenyl halides as modifying reagents for polypeptides and proteins. Quantitative evaluation of tryptophan and cystei residues in proteins.
35. [Effect of additive compounds of dimethylthiolpropanol and mercury bichloride].
36. TRYPTOPHAN METABOLISM IN SPECIAL PAIRS OF TWINS.
37. [Contraceptive drugs].
38. URINARY EXCRETION OF TRYPTOPHAN METABOLITES IN PATIENTS WITH RENAL PELVIS AND PARENCHYMA TUMOURS.
39. Conformational transition of the synthetic 2-15 N-terminal fragment of hen egg-white lysozyme.
40. On the determination of small amounts of tryptophan metabolites and their occurrence in normal human urine.
41. [Studies on 5 beta-ketosteroids. VI. Pyrimidine and pteridine derivatives of 3,12-diketo- and 7,12 diketocholanic acids].
42. ASPECTS OF DISORDERS OF THE KYNURENINE PATHWAY OF TRYPTOPHAN METABOLISM IN MAN.
43. [Aspects of the metabolism of tryptophan in patients with vesical tumors and other urinary diseases].
44. Quantitative determination of tryptophan metabolites (via kynurenine) in biologic fluids.
45. Synthesis of bradykinin via oximinopyrazoline active esters (OPmp).
46. Sulfenyl halides as modifying reagents for polypeptides and proteins. II. Modification of cysteinyl residues.
47. Sulfenyl halides as modifying reagents for polypeptides and proteins. IV. On the conversion of 2-thio-aryl-tryptophan to 2-hydroxy-tryptophan.
48. [Studies on 5 beta-ketosteroids. VII. Pyrimidine and pteridine derivatives of 3,7,12-triketocholanic acid].
49. Isolation of Kynurenine and 3-hydroxykynurenine from human pathological urine.
50. Preferential hydrolysis of kynurenine peptides.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.